These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 5815222)
21. [Hyperprolinemia type I]. Thomsen B; Vetner M; Rosleff F; Reske-Nielsen E Ugeskr Laeger; 1974 Oct; 136(44):2460-1. PubMed ID: 4420280 [No Abstract] [Full Text] [Related]
22. [Hyperprolinemia type II]. Thomsen B; Vetner M; Rosleff F; Reske-Nielsen E Ugeskr Laeger; 1974 Nov; 136(45):2530. PubMed ID: 4420281 [No Abstract] [Full Text] [Related]
23. Type I hyperprolinemia in a family suffering from aniridia and severe dystrophia of ocular tissues. Fusco G; Carlomagno S; Romano A; Rinaldi E; Cedrola G; Cianciaruso L; Curto A; Rosolia S; Auricchio G Ophthalmologica; 1976; 173(1):1-10. PubMed ID: 958671 [No Abstract] [Full Text] [Related]
29. Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. Di Rosa G; Pustorino G; Spano M; Campion D; Calabrò M; Aguennouz M; Caccamo D; Legallic S; Sgro DL; Bonsignore M; Tortorella G Psychiatr Genet; 2008 Feb; 18(1):40-2. PubMed ID: 18197084 [TBL] [Abstract][Full Text] [Related]
30. Biochemical and clinical features of hereditary hyperprolinemia. Mitsubuchi H; Nakamura K; Matsumoto S; Endo F Pediatr Int; 2014 Aug; 56(4):492-6. PubMed ID: 24931297 [TBL] [Abstract][Full Text] [Related]
31. Editorial: Histidinaemia: To treat or not to treat? Lancet; 1974 Apr; 1(7860):719. PubMed ID: 4132432 [No Abstract] [Full Text] [Related]
32. [A system of early screening for inborn errors of metabolism: methods and results for hereditary tyrosinemia]. Bélanger M; Saint-Hilaire B; Bélanger L Union Med Can; 1973 Feb; 102(2):294-302. PubMed ID: 4709460 [No Abstract] [Full Text] [Related]
33. Treatment of hydroxyprolinemia and hyperprolinemia. Efron ML Am J Dis Child; 1967 Jan; 113(1):166-9. PubMed ID: 6015897 [No Abstract] [Full Text] [Related]
35. Low proline diet in type I hyperprolinaemia. Harries JT; Piesowicz AT; Seakins JW; Francis DE; Wolff OH Arch Dis Child; 1971 Feb; 46(245):72-81. PubMed ID: 5555491 [TBL] [Abstract][Full Text] [Related]
36. Recovery after dietary treatment of an infant with features of tyrosinosis. Harries JT; Seakins JW; Ersser RS; Lloyd JK Arch Dis Child; 1969 Apr; 44(234):258-67. PubMed ID: 5779435 [No Abstract] [Full Text] [Related]
37. Congenital renal dysplasia, retinal dysplasia and mental retardation associated with hyperprolinuria and hyper-oh-prolinuria. Rokkones T; Loken AC Acta Paediatr Scand; 1968 May; 57(3):225-9. PubMed ID: 5706039 [No Abstract] [Full Text] [Related]
38. Hereditary hematuria associated with mental retardation, convulsions, abnormal EEG and ocular abnormalities. Hirooka M; Ono T; Kubota N; Yoshioka K; Ikeda S Tohoku J Exp Med; 1969 Jun; 98(2):199-211. PubMed ID: 5811104 [No Abstract] [Full Text] [Related]
39. Dicarboxylic aminoaciduria: an inborn error of glutamate and aspartate transport with metabolic implications, in combination with a hyperprolinemia. Teijema HL; van Gelderen HH; Giesberts MA; Laurent de Angulo MS Metabolism; 1974 Feb; 23(2):115-23. PubMed ID: 4810805 [No Abstract] [Full Text] [Related]
40. Long-term clinical outcome, therapy and mild mitochondrial dysfunction in hyperprolinemia. van de Ven S; Gardeitchik T; Kouwenberg D; Kluijtmans L; Wevers R; Morava E J Inherit Metab Dis; 2014 May; 37(3):383-90. PubMed ID: 24173411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]